| Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses (NCT05419830) | University of Pittsburgh | 2022-06-01 |
| TUCSON Study: Tackling Underlying Causes of Sleep Related Nocturia Nocturia (NCT05404828) | University Hospital, Ghent | 2022-02-28 |
| Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) (NCT05368246) | InnoCon Medical | 2022-02-15 |
| Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer (NCT05300308) | Universitaire Ziekenhuizen KU Leuven | 2022-01-21 |
| A Pilot Study to Evaluate PureWick for Nocturia (NCT05090722) | Northwell Health | 2021-12-16 |
| Abdominal Muscle Exercises on Nocturia and Sleep Quality in Women With Type 2 Diabetes (NCT05222477) | Cairo University | 2021-11-15 |
| Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults (NCT05464589) | Dow University of Health Sciences | 2021-08-10 |
| Validation of Capillary Serum Sodium Levels (NCT05414279) | University Hospital, Ghent | 2021-04-30 |
| Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis (NCT04528784) | University of Limerick | 2020-10-14 |
| NOGO for an Overactive Bladder (NCT04357223) | SagaNatura | 2020-05-01 |
| Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy (NCT02961114) | Robert W. Alexander, MD, FICS | 2019-11-01 |
| Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A (NCT04305743) | University of South Florida | 2019-10-09 |
| Food and Salt Handling in Diuresis (NCT04526340) | University Hospital, Ghent | 2019-06-24 |
| Discovering the Effect of Venous Insufficiency on Nocturia (DEVINe) (NCT03928197) | University Hospital, Ghent | 2019-05-01 |
| Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production (NCT03883724) | University of Pittsburgh | 2019-02-01 |
| Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders (NCT03623880) | Northwestern University | 2018-09-03 |
| Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women (NCT04433897) | University Hospital, Ghent | 2018-06-01 |
| Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men (NCT03043222) | St. Louis University | 2018-03-01 |
| Effectiveness of Bryophyllum in Nocturia-Therapy (NCT04480658) | University of Zurich | 2018-01-01 |
| A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults (NCT03201419) | Ferring Pharmaceuticals | 2017-07-27 |
| Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects (NCT03051009) | Ferring Pharmaceuticals | 2017-01-11 |
| Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects (NCT02904759) | Ferring Pharmaceuticals | 2016-09-01 |
| Investigation of the Effect of the Female Urinary Microbiome on Incontinence (NCT02835846) | Loyola University | 2016-09-01 |
| Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects (NCT02905682) | Ferring Pharmaceuticals | 2016-09-01 |
| Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (NCT02637960) | Vantia Ltd | 2016-03-01 |
| Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial (NCT02646826) | Wellesley Pharmaceuticals, LLC | 2016-01-01 |
| Study of Minirin Melt® in Adult Patients With Nocturia (NCT03089073) | Ferring Pharmaceuticals | 2015-07-13 |
| Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older (NCT02262936) | Mount Sinai Hospital, Canada | 2015-07-01 |
| Hormonal Influences on Diuresis (NCT04891926) | University Hospital, Ghent | 2015-05-01 |
| Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS) (NCT02410135) | Southern Illinois University | 2015-04-01 |
| Melatonin for Nocturia in Parkinson's Disease (NCT02359448) | University College, London | 2015-04-01 |
| Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia (NCT02106182) | JW Pharmaceutical | 2014-01-02 |
| The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence (NCT02396160) | The University of Queensland | 2013-08-01 |
| Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4 (NCT01900704) | Serenity Pharmaceuticals, Inc. | 2013-08-01 |
| Spanish (Spain) Validation of a Specific Symptomatic Questionnaire for Patients With Nocturia (NCT01816724) | Corporacion Parc Tauli | 2013-03-01 |
| Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women (NCT01684800) | Ferring Pharmaceuticals | 2012-09-01 |
| Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men (NCT01694498) | Ferring Pharmaceuticals | 2012-09-01 |
| Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease (NCT01520948) | Atlanta VA Medical Center | 2012-09-01 |
| The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion (NCT02068560) | University of Aarhus | 2012-05-01 |
| The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia (NCT01576900) | Seoul National University Hospital | 2012-04-01 |
| Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study (NCT01439997) | University Hospital, Ghent | 2012-03-26 |
| A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia (NCT01552395) | Ferring Pharmaceuticals | 2012-03-01 |
| Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients (NCT01530451) | Chinese University of Hong Kong | 2012-03-01 |
| Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary (NCT01552343) | Ferring Pharmaceuticals | 2012-03-01 |
| Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia (NCT02151253) | Duke University | 2011-05-01 |
| Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia (NCT01357356) | Serenity Pharmaceuticals, Inc. | 2011-05-01 |
| Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH) (NCT01330927) | Vantia Ltd | 2011-03-01 |
| Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients (NCT01262456) | Ferring Pharmaceuticals | 2011-02-01 |
| Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients (NCT01223937) | Ferring Pharmaceuticals | 2010-11-01 |
| Efficacy and Safety of Gabapentin in Treating Overactive Bladder (NCT01486706) | Michael E. Chua | 2010-10-01 |
| VA106483 Dose Response in Females (NCT01171391) | Vantia Ltd | 2010-07-01 |
| Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo (NCT01184859) | Ferring Pharmaceuticals | 2010-07-01 |
| Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia (NCT01259128) | Serenity Pharmaceuticals, Inc. | 2010-04-01 |
| A Study of Minirin Melt in Patients With Nocturia (NCT01212224) | Ferring Pharmaceuticals | 2010-01-01 |
| Efficacy Study of VA106483 in Males With Nocturia. (NCT01038843) | Vantia Ltd | 2009-12-01 |
| Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness (NCT01018225) | Cognitive Research Corporation | 2009-11-01 |
| Long Term Safety Assessment of SER120 in Patients With Nocturia (NCT00981682) | Serenity Pharmaceuticals, Inc. | 2009-08-01 |
| Prevalence and Risk Factors Nocturnal Polyuria in Female OAB (NCT03810027) | National Taiwan University Hospital | 2009-07-01 |
| Treatment of Patients With Nocturia (NCT00937859) | Serenity Pharmaceuticals, Inc. | 2009-06-01 |
| VA106483 Dose Response Study in Elderly Males (NCT00922740) | Vantia Ltd | 2009-06-01 |
| Treatment of Patients With Nocturia (Non-PK Study) (NCT00937378) | Serenity Pharmaceuticals, Inc. | 2009-06-01 |
| A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (NCT00793819) | Watson Pharmaceuticals | 2009-01-01 |
| A Study of Minirin Melt in Patients With Nocturia (NCT01222598) | Ferring Pharmaceuticals | 2008-09-01 |
| Efficacy and Safety of VA106483 in Elderly Males (NCT00879138) | Vantia Ltd | 2008-08-01 |
| Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe) (NCT00824200) | Atlanta VA Medical Center | 2008-07-01 |
| Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men (NCT00700583) | Seoul National University Hospital | 2008-05-01 |
| An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults (NCT00615836) | Ferring Pharmaceuticals | 2007-12-01 |
| Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia (NCT00477490) | Ferring Pharmaceuticals | 2007-05-01 |
| Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP) (NCT00826527) | Seattle Urology Research Center | 2007-01-01 |
| Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity (NCT00902655) | Samsung Medical Center | 2004-04-01 |